Sign inJoin waitlistJoin the waitlist

Amit Verma

Deputy Director, Montefiore Einstein Comprehensive Cancer Center · Montefiore Medical Center/Albert Einstein College of Medicine

Credentials: · · · ·

History

Montefiore Einstein Comprehensive Cancer Center · Montefiore Medical Center/Albert Einstein College of Medicine
Present
Oncology Department · Montefiore Medical Center/Albert Einstein College of Medicine
Present
Blood Cancer Institute Center · Montefiore Medical Center/Albert Einstein College of Medicine
Present

University of Illinois College of Medicine at Chicago
1999–2001
Northwestern University
1998–1999
Internal Medicine
University of Illinois College of Medicine at Chicago
1995–1998
ALL INDIA INST OF MED SCI, ANSARI NAGAR, NEW DELHI, DELHI
1991–1995

Research

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Cancer Discovery · 2020 · Co-senior of 19 authors · Corresponding · 589 citations
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
New England Journal of Medicine · 2020 · 449 citations
Mechanism of action of lenalidomide in hematological malignancies
Review · Journal of Hematology & Oncology · 2009 · Last of 7 authors · Corresponding · 368 citations

Aditi Shastri
85 papers · 1 as a fellow
Ioannis Mantzaris
63 papers · 2 as a fellow
Noah Kornblum
47 papers
Mendel Goldfinger
45 papers
Kira Gritsman
43 papers
Alejandro Sica
38 papers
IB
Ira Braunschweig
38 papers
Nishi Shah
33 papers · 12 as a fellow
Leonidas Platanias
31 papers
MJ
Murali Janakiram
30 papers
John Greally
26 papers · 1 as a fellow
Marina Konopleva
23 papers

Grants

Modulating Iron Trafficking to Ameliorate Ineffective Erythropoiesis in MDS
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $871K · Icahn School of Medicine at Mount Sinai
2026–2030
Montefiore Einstein Clinical Oncology Training Program in the Bronx
National Cancer Institute · K12
Contact PI · $2.1M · Albert Einstein College of Medicine
2023–2028
Therapeutic Targeting of IRAK4 in MDS
National Cancer Institute · R01
Contact PI · $2.6M · Albert Einstein College of Medicine
2022–2027
Blood Mutations and Cancer Associations Among WTC-Exposed Firefighters
NIOSH · R21
Contact PI · $499.9K · Albert Einstein College of Medicine
2025–2027

Clinical trials

Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Principal investigator · Terminated · Phase 1
Albert Einstein College of Medicine
2013–2018
Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia
Principal investigator · Completed · Phase 2
Albert Einstein College of Medicine
2012–2020
Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy
Principal investigator · Unknown · Phase 2
Kansas City Veteran Affairs Medical Center
2008–2012
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
Study chair · Completed · Phase 1
Albert Einstein College of Medicine
2006–2010